LongeVC is a venture capital firm based in Washington D.C. that invests in early-stage biotechnology and longevity-focused companies. They aim to support founders in bringing innovative biotech solutions to market.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
LongeVC is a venture capital firm located in Washington D.C., dedicated to investing in early-stage companies that are pioneering advancements in biotechnology and longevity. The firm focuses on supporting founders who are developing innovative solutions in personalized medicine, advanced diagnostics, and foundational platform technologies. LongeVC's investment strategy encompasses pre-clinical and clinical stage drug development companies that investigate the molecular and cellular mechanisms of aging, as well as integrated healthcare solutions that expedite drug discovery and testing. By fostering a collaborative ecosystem, LongeVC empowers its portfolio companies to thrive and contribute to the future of healthcare.
LongeVC invests in early-stage companies that are developing innovative solutions in personalized medicine, advanced diagnostics, and foundational platform technologies. Their investment thesis includes pre-clinical and clinical stage drug development companies that explore the molecular and cellular mechanisms of aging, as well as integrated healthcare solutions that facilitate faster drug discovery and testing.
LongeVC provides strategic support to its portfolio companies, leveraging its expertise in biotechnology and longevity to help founders navigate the complexities of drug development and market entry. The firm aims to facilitate connections within the industry and provide resources that enhance the growth and success of its investments.
LongeVC focuses on early-stage companies in biotechnology and longevity, particularly those developing personalized medicine, advanced diagnostics, and foundational platform technologies. They invest in pre-clinical and clinical stage drug development companies that explore the mechanisms of aging.
Founders can pitch their ideas through the firm's website at longevc.com or by emailing their pitch deck to hq@longevc.com. It is advisable to include a clear overview of the business model, market opportunity, and team background.
LongeVC specializes in biotechnology and longevity, making it one of the few firms dedicated to this sector. Their deep expertise in drug development and market entry provides significant value to portfolio companies.
The firm primarily invests in companies based in the United States, focusing on startups that align with their investment thesis in biotechnology and longevity.
LongeVC actively supports its portfolio companies by providing strategic guidance, industry connections, and resources to help navigate the complexities of drug development and market entry.
While specific fund sizes are not disclosed, LongeVC invests in early-stage rounds, typically providing check sizes that align with pre-seed, seed, seed-plus, and Series A funding stages.
Organizations that do similar work to LongeVC.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorInvesting in the future of life sciences and technology.
InvestorEmpowering innovation through strategic investments.
InvestorEmpowering high-growth potential companies in Asia-Pacific.
Superscout Pro
Is this page right?Reviewed · How the research works